Mission: The objective of the CCCWFU Microarray Shared Resource is to provide Cancer Center members with a competitive and cutting-edge environment for cancer genomics research. The Shared Resource accomplishes this goal by providing faculty with comprehensive and cost-effective microarray technologies and bioinformatics support to facilitate RNA expression profiling, single nucleotide polymorphism (SNP) genotyping, genome copy-number analysis, and methylation profiling using Affymetrix GeneChip oligonucleotide arrays. The accomplishment of these objectives has, in part, been facilitated by recent modifications to the Shared Resource, including the recruitment of Dr. Lance D. Miller as Director, and the addition of a microarray bioinformatics expert to facilitate high quality, detailed analysis of microarray data. Assets: The Microarray Shared Resource has a modern infrastructure that includes the GeneChip Scanner 3000 7G multi-color scanner (recently upgraded to accommodate the MegAllele system for targeted genotyping);three GeneChip 450 fluidics stations;two GeneChip hybridization ovens and four high-speed computer workstations for data analysis workflows. Computational tools for data processing and low-level array analysis are provided by the Affymetrix GeneChip Command Console software (AGCC; released September 2008) which includes basic solutions for data normalization, analysis of expression, genotype and copy-number data, registration of samples and arrays, and management of multi-chip datasets. For advanced data analysis, the Shared Resource now maintains an annual license to the Partek Genomics Suite software - a comprehensive suite of advanced statistical methods and interactive data visualization tools. Usage &Future Directions: In the previous 1-year reporting period, the Microarray Shared Resource has been fully engaged, operating at near maximal capacity, performing 885 microarray hybridizations and providing technical and analytical resources to more than twice as many funded Center members as compared to previous years (1.8 to 5.5-fold more than seen in the past 3 years). Continued development of bioinformatics resources and acquisition of new array technologies are expected to further bolster cancer genomics research at the CCCWFU in the coming years.

Public Health Relevance

Cancer is a disease of the genome and microarray technologies are a valuable resource for investigating the genomic and molecular underpinnings of cancer formation, progression and response to treatment. Further development of the bioinformatics capabilities of the Shared Resource will be valuable to the clinical translation of discoveries made by Cancer Center investigators.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA012197-39
Application #
8617237
Study Section
Subcommittee B - Comprehensiveness (NCI)
Project Start
Project End
Budget Start
2014-02-01
Budget End
2015-01-31
Support Year
39
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Type
DUNS #
City
Winston-Salem
State
NC
Country
United States
Zip Code
27157
Widner, D Brooke; Park, Sun H; Eber, Matthew R et al. (2018) Interactions Between Disseminated Tumor Cells and Bone Marrow Stromal Cells Regulate Tumor Dormancy. Curr Osteoporos Rep 16:596-602
Liu, Liang; Ruiz, Jimmy; O'Neill, Stacey S et al. (2018) Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1. Mol Cancer 17:81
Sirkisoon, Sherona R; Carpenter, Richard L; Rimkus, Tadas et al. (2018) Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer. Oncogene 37:2502-2514
Goyal, Amrita; Carter, Joi B; Pashtan, Itai et al. (2018) Very low-dose versus standard dose radiation therapy for indolent primary cutaneous B-cell lymphomas: A retrospective study. J Am Acad Dermatol 78:408-410
Su, Weijun; Hong, Lixin; Xu, Xin et al. (2018) miR-30 disrupts senescence and promotes cancer by targeting both p16INK4A and DNA damage pathways. Oncogene 37:5618-5632
Miller Jr, David P; Denizard-Thompson, Nancy; Weaver, Kathryn E et al. (2018) Effect of a Digital Health Intervention on Receipt of Colorectal Cancer Screening in Vulnerable Patients: A Randomized Controlled Trial. Ann Intern Med 168:550-557
Rimkus, Tadas K; Carpenter, Richard L; Sirkisoon, Sherona et al. (2018) Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44. Cancer Res 78:2589-2600
Bonin, Keith; Smelser, Amanda; Moreno, Naike Salvador et al. (2018) Structured illumination to spatially map chromatin motions. J Biomed Opt 23:1-8
Rogers, LeAnn C; Davis, Ryan R; Said, Naveen et al. (2018) Blocking LPA-dependent signaling increases ovarian cancer cell death in response to chemotherapy. Redox Biol 15:380-386
Maggiore, Ronald J; Callahan, Kathryn E; Tooze, Janet A et al. (2018) Geriatrics fellowship training and the role of geriatricians in older adult cancer care: A survey of geriatrics fellowship directors. Gerontol Geriatr Educ 39:170-182

Showing the most recent 10 out of 548 publications